GAINESVILLE, Fla. and BOCA RATON, Fla., March 14, 2016 /PRNewswire-USNewswire/ -- The Florida Institute for the Commercialization of Public Research (the Institute) is pleased to announce that Jackson Streeter, M.D. has been appointed as its chief executive officer. Most recently Dr. Streeter served as the CEO of Banyan Biomarkers of Alachua, FL. During his time the company received over $75M in contracts and grants with the Department of Defense and raised $10M in private investment for the development of a first ever blood test for traumatic brain injury.
The Institute is a non-profit organization that supports new company and job creation by bridging early funding gaps for companies spinning out of Florida universities. Leveraging a $2B research base, the Institute works collaboratively with technology licensing officers across the state to connect the dots between research, discovery and commercialization, and supports companies whose products are solving some of today's toughest global challenges.
Prior to serving as CEO of Banyan Biomakers, Dr. Streeter founded and served as CEO for PhotoThera, Inc. where he raised over $120M in private capital and was responsible for the design and management of five U.S. and international clinical trials. He was also the co-founder of American Veterinary Laser, inventor of over twenty patents and author on multiple scientific publications. Dr. Streeter has served on the following boards and executive committees: Florida Research Consortium, Governor's Life Science Task Force for the State of Florida, FBI counter terrorism south east working group, Walter H. Coulter Center Committee at the University of Miami and the Gainesville Chamber of Commerce Board of Directors.
Dr. Streeter served as an Officer in the U.S. Navy, completing a general surgery internship at Naval Regional Medical Center in Portsmouth, Virginia and then primary Flight School at Naval Air Station Pensacola, Florida. During his military service, he was the first Naval Flight Surgeon selected as a TOPGUN staff instructor, served on several overseas deployments and was awarded the Navy Achievement Medal and the Navy Commendation Medal.
"Dr. Streeter will be a great asset to the Institute, bringing his extensive experience working with the startup and investment communities to Florida-based companies," said Rick Wassel, chairman of the Institute board of directors. "The Institute is at a critical point in its development and plays a vital role within Florida's innovation ecosystem, and we look forward to Dr. Streeter's leadership and vision."
"I am delighted to join the Institute and support the commercialization efforts of Florida's great universities and the new companies and important products that are being launched," said Dr. Streeter. "This is an exciting time in the development of Florida's innovation economy, and working together with our public and private sector partners we will continue to accelerate investment and job growth in Florida to generate prosperity for generations to come."
About the Institute
Formed by the Florida Legislature in 2007, the Florida Institute for the Commercialization of Public Research is a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida's state universities and private research institutions to leverage a $2B+ research base and form investable companies that create clean jobs in new industries that are driving the global economy. With funding from the State of Florida through the Department of Economic Opportunity, and through the generosity of mentors, advisors and donors, the Institute provides company building services, and seed funding through the Florida Technology Seed Capital Fund, to promising Florida startups. Forty-eight companies have been funded to date, and the Institute's economic impact through June 30, 2015 was $379 million, a return on investment of 14 times to the State of Florida.
Chief Operating Officer
Institute for the Commercialization of Public Research
SOURCE Florida Institute for the Commercialization of Public Research